The emerging role of pectoral nerve block (PECS block) in breast surgery: A case-matched analysis.
Alessandro FancelluTeresa PerraChiara NinniriPietrina CottuGiulia DeianaClaudio F FeoAlberto PorcuPublished in: The breast journal (2020)
To evaluate the benefits of pectoral nerve block (PECS block) in breast cancer surgery, we compared outcomes of 100 patients receiving PECS vs 107 without PECS. Intraoperative use of fentanyl (P < .001) acetaminophen (P = .02), morphine (P < .01), and nonsteroidal anti-inflammatory drugs (NSAIDS) (P < .01) was lower in the PECS group. Occurrence of postoperative nausea and vomiting (PONV) was lower in the PECS group (P = .04). On postoperative day 1, the use of acetaminophen (P = .23), morphine (P = .83), and NSAIDS (P = .4) did not differ. Twenty-one patients received surgery with PECS block plus sedation alone. PECS block can reduce intraoperative use of opioids and analgesic drugs, and is associated with reduced occurrence of PONV. Selected patients can receive breast-conserving surgery with PECS plus sedation, avoiding general anesthesia.
Keyphrases
- minimally invasive
- coronary artery bypass
- end stage renal disease
- patients undergoing
- newly diagnosed
- ejection fraction
- anti inflammatory drugs
- chronic kidney disease
- risk assessment
- surgical site infection
- peritoneal dialysis
- liver injury
- squamous cell carcinoma
- patient reported outcomes
- spinal cord injury
- intensive care unit
- neuropathic pain
- lymph node
- drug induced
- pain management
- coronary artery disease
- skeletal muscle
- weight loss
- rectal cancer
- extracorporeal membrane oxygenation
- percutaneous coronary intervention